Physician profile
Munish Sharma
NPI 1053703553
$1,129.46
in general payments reported to CMS, 2019-2025
13 companies · $74.75 in 2025
The $74.75 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $261 · 2021: $201 · 2023: $162 · 2024: $187 · 2025: $74.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $206.48 | 2020-2024 | Uptravi |
| Paratek Pharmaceuticals, INC. | $200.33 | 2019-2021 | |
| United Therapeutics Corporation | $121.78 | 2024-2025 | Tyvaso |
| Glaxosmithkline, LLC. | $121.23 | 2019-2023 | Nucala, Arexvy |
| Inari Medical, INC. | $116.34 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $108.72 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $58.29 | 2021 | |
| Advanced Respiratory, INC | $47.71 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $37.51 | 2020 | |
| Boston Scientific Corporation | $32.84 | 2024 | |
| Ekos Corporation | $27.63 | 2019 | |
| Mallinckrodt Hospital Products INC. | $26.92 | 2023 | Terlivaz |
| Insmed, INC. | $23.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munish Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.